Part of the TeachMe Series

Haematuria

star star star star star
based on 1 ratings

Original Author(s): Laurence Tupper
Last updated: March 26, 2019
Revisions: 6

Original Author(s): Laurence Tupper
Last updated: March 26, 2019
Revisions: 6

format_list_bulletedContents add remove

Haematuria is the presence of blood in the urine, either visible (seen by the naked eye) or non-visible (confirmed by urine dipstick or urine microscopy).

Fig 1 – The urinary tract

It is never a normal finding and has a range of urological and non-urological causes, both malignant and benign, which commonly require further investigation.

Classification

Haematuria is classified into:

  • Visible haematuria (VH): formerly ‘macroscopic’ or ‘gross’ haematuria. Blood is visible in the urine, colouring it pink, red, or dark brown
  • Non-visible haematuria (NVH): formerly ‘microscopic’ or ‘dipstick positive’. Blood is present in the urine on urinalysis, but not visible. This can be further categorised into:
    • Symptomatic non-visible haematuria (s-NVH): haematuria (confirmed on urinalysis/microscopy) presents with associated symptoms, such as suprapubic pain or renal colic.
    • Asymptomatic non-visible haematuria (a-NVH): haematuria (confirmed on urinalysis/microscopy) with no associated symptoms.

Pseudohaematuria

Pseudohaematuria is red or brown urine that is not secondary to the presence of haemoglobin.

Causes include medication (such as rifampicin or methyldopa), hyperbilirubinuria, myoglobinuria, and certain foods (such as beetroot or rhubarb)

Aetiology

There is a vast array of causes of haematuria; these can be stratified anatomically (Fig. 2).

The most common causes include urinary tract infection (UTI), urothelial carcinoma, stone disease, adenocarcinoma of the prostate, and benign prostatic hypertrophy (BPH).

Figure 2 – Classification of haematuria

Urological causes of haematuria include:

  • Infection, including pyelonephritis, cystitis, or prostatitis
  • Malignancy, including urothelial carcinoma or prostate adenocarcinoma
  • Renal calculi
  • Trauma or recent surgery
  • Radiation cystitis
  • Parasitic, most commonly schistosomiasis

Clinical Features

The degree of haematuria* should be quantified where possible (e.g. pink vs dark red), and the presence or clots or not. Also enquire about the timing in the stream (as total haematuria suggests as a bladder or upper tract source, whilst terminal haematuria suggests potential severe bladder irritation)

*Bright pink, orange, or dark brown coloured urine may suggest non-urological causes

Clarify any associated symptoms, such as any Lower Urinary Tract Symptoms (LUTS), fevers or rigors, suprapubic pain, flank pain, or weight loss, or recent trauma.

Ensure to assess the drug history* and smoking status, due to the strong association with smoking and urological malignancies. Any exposure to industrial carcinogens (increased risk of bladder cancer) or recent foreign travel (increased risk of schistosomiasis from certain areas) should be clarified.

*Although patients on anti-platelets or anti-thrombotic agents may have a higher incidence of bleeding on these medications, they should still be investigated as normal

An abdominal examination is essential, alongside potential digital rectal examination and / or examination of the external genitalia depending on the presentation.

Investigations

Initial Investigations

Urinalysis (urine dipstick testing) is usually the primary investigation in all settings*. The presence of nitrites and/or leukocytes on urinalysis may also indicate infection as a potential underlying cause.

Baseline bloods (FBC, U&Es, and clotting) should be performed. Additionally, prostate specific antigen (PSA) testing may be indicated (after appropriate counselling) in patients where prostatic pathology is considered a possible cause of haematuria.

In those with deranged renal function or suspected of a nephrological cause, urinary protein levels (spot albumin:creatinine ratio or protein:creatinine ratio) may be warranted.

Patients should be referred for further investigations by a specialist service.

*It is worth noting that ‘trace’ blood on a urinalysis does not constitute haematuria – ≥1+ blood is required to constitute haematuria

Urological Referral Criteria for Haematuria

Current NICE guidelines recommend urgent referral to an adult urological service for specialist haematuria investigation in the following:

  • Aged ≥45yrs with either:
    • Unexplained visible haematuria without urinary tract infection
    • Visible haematuria that persists or recurs after successful treatment of urinary tract infection
  • Aged 60yrs with have unexplained non‑visible haematuria and either dysuria or a raised white cell count on a blood test.

Patients with asymptomatic non-visible haematuria on two out of three tests should also be referred for further investigation.

Referral to a nephrologist may be warranted in patients with a likely nephrological diagnosis, evidence of declining GFR, stage 4/stage 5 chronic kidney disease, proteinuria with haematuria, or those <40 years old with hypertension.

Specialist Investigations

Flexible cystoscopy is the gold standard investigation for assessing the lower urinary tract and should be performed in all cases that meet the criteria for further investigation where feasible (Fig. 3). This is often performed under local anaesthetic at a one-stop haematuria clinic.

Whilst more commonly used in follow-up of patients with proven malignancy, some centres will also send urine cytology in the intial assessment for haematuria as a further adjunct assessment.

Figure 3 – Cystoscopy on a 29yr old male, demonstrating (A) normal bladder wall (B) cystoscope entering at the bladder neck (C) an inflamed urethra

Upper urinary tract imaging is also warranted in cases of haematuria:

  • US KUB imaging is a cheap and non-invasive method, and is typically employed for cases of non-visible haematuria
  • CT Urogram is more definitive imaging, albeit with a higher radiation exposure, and is typically used for cases of visible haematuria

Management

Management is treatment of the underlying pathology.

Approximately 20% of patients presenting with visible haematuria and 5% of patients presenting with non-visible haematuria are found to have an underlying malignancy.

Key Points

  • There are a vast array of causes of haematuria, the most common being infection, malignancy and urinary stone disease
  • Haematuria can be classified as visible (VH), symptomatic non-visible (s-NVH) or asymptomatic non-visible (a-NVH)
  • Referral to specialist services is required for all patients with VH and s-NVH, and some patients with a-NVH depending on the results of other baseline investigations
  • Flexible cystoscopy is the gold standard investigation for assessing the lower urinary tract